angustmycin a has been researched along with 5-iodotubercidin in 1 studies
Studies (angustmycin a) | Trials (angustmycin a) | Recent Studies (post-2010) (angustmycin a) | Studies (5-iodotubercidin) | Trials (5-iodotubercidin) | Recent Studies (post-2010) (5-iodotubercidin) |
---|---|---|---|---|---|
44 | 0 | 7 | 140 | 0 | 42 |
Protein | Taxonomy | angustmycin a (IC50) | 5-iodotubercidin (IC50) |
---|---|---|---|
Chain A, Mitogen-activated protein kinase 3 | Homo sapiens (human) | 0.9 | |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | 1.2 | |
Adenosine kinase | Homo sapiens (human) | 0.1583 | |
Adenosine kinase | Mycobacterium tuberculosis H37Rv | 1.2 | |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.071 | |
Histone-lysine N-methyltransferase, H3 lysine-79 specific | Homo sapiens (human) | 7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheviet, T; Lefebvre-Tournier, I; Peyrottes, S; Wein, S | 1 |
1 review(s) available for angustmycin a and 5-iodotubercidin
Article | Year |
---|---|
Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues.
Topics: Antimalarials; Biological Transport; Drug Design; Erythrocytes; Humans; Inhibitory Concentration 50; Malaria; Nucleosides; Nucleotides; Plasmodium falciparum; Purines; Pyrimidines | 2019 |